Kezar Life Sciences, Inc. (KZR) financial statements (2021 and earlier)

Company profile

Business Address 4000 SHORELINE COURT, SUITE 300
SOUTH SAN FRANCISCO, CA 94080
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments14078107
Cash and cash equivalents211524
Short-term investments1196383
Prepaid expense322
Other current assets210
Total current assets:14581110
Noncurrent Assets
Operating lease, right-of-use asset34
Property, plant and equipment345
Other noncurrent assets000
Total noncurrent assets:785
TOTAL ASSETS:15290115
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities553
Accounts payable210
Accrued liabilities343
Debt 1 
Deferred rent credit  0
Other liabilities000
Other undisclosed current liabilities1  
Total current liabilities:663
Noncurrent Liabilities
Long-term debt and lease obligation45 
Operating lease, liability45
Liabilities, other than long-term debt  3
Deferred rent credit  3
Other undisclosed noncurrent liabilities(4)  
Total noncurrent liabilities:453
Total liabilities:11116
Stockholders' equity
Stockholders' equity attributable to parent14178109
Common stock000
Additional paid in capital267163158
Accumulated other comprehensive loss(0)(0)(0)
Accumulated deficit(126)(84)(49)
Total stockholders' equity:14178109
TOTAL LIABILITIES AND EQUITY:15290115

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Operating expenses(43)(37)(25)
Operating loss:(43)(37)(25)
Loss before gain (loss) on sale of properties:(43)(37)(25)
Other undisclosed net income122
Net loss available to common stockholders, diluted:(42)(35)(23)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Net loss:(42)(35)(23)
Comprehensive loss:(42)(35)(23)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent00(0)
Comprehensive loss, net of tax, attributable to parent:(42)(35)(23)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: